Prevalence of Chronic Metoclopramide Use and Associated Diagnoses in the US Pediatric Population

Rachel B Weinstein1, Daniel Fife, Sheldon Sloan

  • 1Epidemiology, Janssen Research and Development LLC, 1125 Trenton-Harbourton Rd, Titusville, NJ, 08560, USA, rweinst1@its.jnj.com.

Paediatric Drugs
|May 28, 2015
PubMed

Insights

Many US children use metoclopramide chronically, despite its risks. This study estimated the prevalence of chronic metoclopramide use in children and identified gastroesophageal reflux disease (GERD) as a likely indication.

Area of Science:

  • Pediatric pharmacology
  • Gastroenterology
  • Public health

Background:

  • Metoclopramide is a key medication for promoting gastrointestinal motility in the US.
  • Chronic use in children is concerning due to potential central nervous system complications.
  • The medication's approved indications in adults include GERD and diabetic gastroparesis.

Purpose of the Study:

  • To estimate the prevalence of chronic metoclopramide use among children in the United States.
  • To identify common diagnoses associated with chronic metoclopramide prescriptions in pediatric populations.
  • To focus on gastroesophageal reflux disease (GERD) as a probable indication for chronic use in children.

Main Methods:

  • Utilized two large health services databases covering privately and publicly insured children.
  • Defined chronic metoclopramide use using liberal (≥35 days' supply) and conservative (≥130 days' supply) criteria over a 6-month period.
  • Applied derived proportions to US population estimates to determine national prevalence.

Main Results:

  • An estimated 89,020 US children used metoclopramide chronically under the liberal definition.
  • Approximately 28,222 US children used metoclopramide chronically under the conservative definition.
  • Chronic metoclopramide use was substantial in both privately and publicly insured pediatric populations.

Conclusions:

  • Significant numbers of US children are treated with metoclopramide for extended periods.
  • Symptoms consistent with GERD appear to be a primary driver for this chronic use.
  • The findings highlight the need to weigh metoclopramide's risks against benefits in pediatric chronic treatment.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
821
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
1.1K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K